BCL2 and breast carcinoma: Also, METTL3 was reportedly upregulated in breast cancer cells and tissues, with gene silencing significantly inhibiting cell proliferation and promoting apoptosis by regulating Bcl-2, thereby indicating an oncogenic role for METTL3 in breast cancer progression (Wang et al., 2020).